These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3495188

  • 1. CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
    Roy A, Pickar D, Paul S, Doran A, Chrousos GP, Gold PW.
    Am J Psychiatry; 1987 May; 144(5):641-5. PubMed ID: 3495188
    [Abstract] [Full Text] [Related]

  • 2. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.
    Banki CM, Bissette G, Arato M, O'Connor L, Nemeroff CB.
    Am J Psychiatry; 1987 Jul; 144(7):873-7. PubMed ID: 3496802
    [Abstract] [Full Text] [Related]

  • 3. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.
    Geracioti TD, Loosen PT, Orth DN.
    Biol Psychiatry; 1997 Aug 01; 42(3):165-74. PubMed ID: 9232208
    [Abstract] [Full Text] [Related]

  • 4. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
    Geracioti TD, Orth DN, Ekhator NN, Blumenkopf B, Loosen PT.
    J Clin Endocrinol Metab; 1992 Jun 01; 74(6):1325-30. PubMed ID: 1317385
    [Abstract] [Full Text] [Related]

  • 5. Release of corticotropin after administration of corticotropin-releasing hormone in depressed patients in relation to the dexamethasone suppression test.
    Thalén BE, Kjellman BF, Ljunggren JG, Akner G, Kågedal B, Wahlund B, Wetterberg L.
    Acta Psychiatr Scand; 1993 Feb 01; 87(2):133-40. PubMed ID: 8383420
    [Abstract] [Full Text] [Related]

  • 6. Diazepam-binding inhibitor and corticotropin-releasing hormone in cerebrospinal fluid.
    Roy A, Pickar D, Gold P, Barbaccia M, Guidotti A, Costa E, Linnoila M.
    Acta Psychiatr Scand; 1989 Sep 01; 80(3):287-91. PubMed ID: 2816471
    [Abstract] [Full Text] [Related]

  • 7. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.
    Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti TD, DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW.
    Proc Natl Acad Sci U S A; 2000 Jan 04; 97(1):325-30. PubMed ID: 10618417
    [Abstract] [Full Text] [Related]

  • 8. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP.
    Adv Biochem Psychopharmacol; 1987 Jan 04; 43():183-200. PubMed ID: 3035886
    [Abstract] [Full Text] [Related]

  • 9. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression.
    De Bellis MD, Gold PW, Geracioti TD, Listwak SJ, Kling MA.
    Am J Psychiatry; 1993 Apr 04; 150(4):656-7. PubMed ID: 8465888
    [Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic function.
    Roy A, Pickar D, Linnoila M, Chrousos GP, Gold PW.
    Psychiatry Res; 1987 Mar 04; 20(3):229-37. PubMed ID: 3495811
    [Abstract] [Full Text] [Related]

  • 11. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression.
    Kaye WH, Gwirtsman HE, George DT, Ebert MH, Jimerson DC, Tomai TP, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1987 Feb 04; 64(2):203-8. PubMed ID: 3491830
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
    Heuser I, Bissette G, Dettling M, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Nemeroff CB, Holsboer F.
    Depress Anxiety; 1998 Feb 04; 8(2):71-9. PubMed ID: 9784981
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone suppression in dementia, depression, and normal aging.
    Georgotas A, McCue RE, Kim OM, Hapworth WE, Reisberg B, Stoll PM, Sinaiko E, Fanelli C, Stokes PE.
    Am J Psychiatry; 1986 Apr 04; 143(4):452-6. PubMed ID: 3953888
    [Abstract] [Full Text] [Related]

  • 14. Relationship of cognitive factors to CSF corticotropin-releasing hormone in depression.
    De Jong JA, Roy A.
    Am J Psychiatry; 1990 Mar 04; 147(3):350-2. PubMed ID: 2309955
    [Abstract] [Full Text] [Related]

  • 15. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
    Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield HJ, May C, Post RM, Chrousos GP, Gold PW.
    J Clin Endocrinol Metab; 1991 Feb 04; 72(2):260-71. PubMed ID: 1846869
    [Abstract] [Full Text] [Related]

  • 16. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR, Pieters GF, Pesman GJ, Smals AG, Benraad TJ, Kloppenborg PW.
    J Clin Endocrinol Metab; 1986 Apr 04; 62(4):634-9. PubMed ID: 3005353
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
    Kling MA, Rubinow DR, Doran AR, Roy A, Davis CL, Calabrese JR, Nieman LK, Post RM, Chrousos GP, Gold PW.
    Neuroendocrinology; 1993 Jan 04; 57(1):79-88. PubMed ID: 8097579
    [Abstract] [Full Text] [Related]

  • 18. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects.
    Heuser IJ, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, Yassouridis A, Holsboer F.
    Am J Psychiatry; 1996 Jan 04; 153(1):93-9. PubMed ID: 8540599
    [Abstract] [Full Text] [Related]

  • 19. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M, Allolio B, Würth G, Winkelmann W.
    J Clin Endocrinol Metab; 1993 Jul 04; 77(1):151-6. PubMed ID: 8392081
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.
    Neuropsychopharmacology; 2003 Dec 04; 28(12):2169-78. PubMed ID: 12931142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.